XML 107 R91.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Reporting - Significant expenses (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting    
Revenue $ 813,455 $ 57,336
Cost of revenue (303,290) (3,927,228)
Gross Income (Loss) 510,165 (3,869,892)
Research and Development:    
Salaries and benefits 1,099,840 6,215,323
Direct clinical and non-clinical expenses 151,180 3,072,416
Facilities expenses 190,182 834,406
Non-cash stock based compensation expenses 389,245 623,049
Supplies and materials 25,130 2,195,608
Other Expenses 42,165 409,457
Depreciation expense 12,688 1,112,463
Realized gains - digital assets (8,321,844)  
Unrealized loss - digital assets 9,030,413  
Impairment loss - digital assets 27,188,768  
Impairment loss - other assets   11,207,897
Gain on covered call option (157,570)  
Provision for credit losses 405,331  
Reacquisition of license rights   4,864,600
Asset impairments   11,200,000
Net Operating Expenses 47,231,226 44,868,333
Segment loss 30,055,528 30,535,219
Selling, general and administrative 17,175,698 14,333,114
Other (income) expense, net 1,406,626 (1,080,208)
Net Income (Loss) (45,314,435) (49,818,433)
Corporate / Other    
Research and Development:    
Selling, general and administrative 17,175,698  
Other (income) expense, net (1,406,626)  
Net Income (Loss) (15,769,072)  
Ophthalmic Technology | Operating Segments    
Segment Reporting    
Revenue 14,720 57,336
Cost of revenue (48) (3,927,228)
Gross Income (Loss) 14,672 (3,869,892)
Research and Development:    
Salaries and benefits 1,099,840 6,215,323
Direct clinical and non-clinical expenses 151,180 3,072,416
Facilities expenses 190,182 834,406
Non-cash stock based compensation expenses 389,245 623,049
Supplies and materials 25,130 2,195,608
Other Expenses 42,165 409,457
Depreciation expense 12,688 1,112,463
Impairment loss - other assets   11,207,897
Reacquisition of license rights   4,864,600
Segment loss 1,910,430 30,535,219
Selling, general and administrative   14,333,114
Other (income) expense, net   (1,080,208)
Net Income (Loss) (1,895,758) $ (49,818,433)
Digital Assets | Operating Segments    
Segment Reporting    
Revenue 798,735  
Cost of revenue (303,242)  
Gross Income (Loss) 495,493  
Research and Development:    
Realized gains - digital assets (8,321,844)  
Unrealized loss - digital assets 9,030,413  
Impairment loss - digital assets 27,188,768  
Gain on covered call option (157,570)  
Provision for credit losses 405,331  
Segment loss 28,145,098  
Net Income (Loss) $ (27,649,605)